A group of researchers from the University of Erlangen-Nuremberg has discovered which immune cells migrate from the skin of ...

Discover why psoriasis treatments may lose effectiveness and explore alternatives. Learn about the potential of biologics, ...

Researchers from the Institute for Advanced Chemistry of Catalonia (IQAC) of the Spanish National Research Council (CSIC) have developed a series of light-activatable drug candidates that could serve ...

Jan 6 (Reuters) - Alumis (ALMS.O), opens new tab said on Tuesday its experimental drug met the main goal of improving symptoms of a common skin disease in two late-stage studies, powering its shares ...

BRITS have been urged to be vigilant after a surge in cases of a highly infectious Victorian disease that can trigger ...

Takeda’s zasocitinib has shown strong rates of skin clearance, as well as other benefits, in new study results regarding ...

Alumis Inc. surged on Phase 3 psoriasis data for envudeucitinib. Click for this look at ALMS stock and why I am bullish on ...

Inflammatory bowel disease, or IBD, has become an epidemic in urban cities. Here are the signs to watch out for and when to seek medical treatment.

Experts review warning nail features, from inflammatory conditions to tumours, offering practical guidance on diagnosis and ...

Arrowhead Pharmaceuticals disclosed that its gene-silencing candidates helped people with obesity lose fat, very early ...

Both Phase 3 trials met all primary and secondary endpoints with high statistical significance in patients with moderate-to-severe plaque ...